AAAAAA
Results:
1-20
|
Results: 20
Authors:
von Mehren, M
Arlen, P
Gulley, J
Rogatko, A
Cooper, HS
Meropol, NJ
Alpaugh, RK
Davey, M
McLaughlin, S
Beard, MT
Tsang, KY
Schlom, J
Weiner, LM
Citation: M. Von Mehren et al., The influence of granulocyte macrophage colony-stimulating factor and prior chemotherapy on the immunological response to a vaccine (ALVAC-CEA B7.1) in patients with metastatic carcinoma, CLIN CANC R, 7(5), 2001, pp. 1181-1191
Authors:
Correale, P
Campoccia, G
Tsang, KY
Micheli, L
Cusi, MG
Sabatino, M
Bruni, G
Sestini, S
Petrioli, R
Pozzessere, D
Marsili, S
Fanetti, G
Giorgi, G
Francini, G
Citation: P. Correale et al., Recruitment of dendritic cells and enhanced antigen-specific immune reactivity in cancer patients treated with hr-GM-CSF (Molgramostim) and hr-IL-2: results from a phase Ib clinical trial, EUR J CANC, 37(7), 2001, pp. 892-902
Authors:
Selleri, L
Depew, MJ
Jacobs, Y
Chanda, SK
Tsang, KY
Cheah, KSE
Rubenstein, JLR
O'Gorman, S
Cleary, ML
Citation: L. Selleri et al., Requirement for Pbx1 in skeletal patterning and programming chondrocyte proliferation and differentiation, DEVELOPMENT, 128(18), 2001, pp. 3543-3557
Authors:
Tsang, KY
Ng, TB
Citation: Ky. Tsang et Tb. Ng, Isolation and characterization of a new ribosome inactivating protein, momorgrosvin, from seeds of the monk's fruit Mamordica grosvenorii, LIFE SCI, 68(7), 2001, pp. 773-784
Authors:
Thacher, SM
Vasudevan, J
Tsang, KY
Nagpal, S
Chandraratna, RAS
Citation: Sm. Thacher et al., New dermatological agents for the treatment of psoriasis, J MED CHEM, 44(3), 2001, pp. 281-297
Authors:
Wallace, PK
Tsang, KY
Goldstein, J
Correale, P
Jarry, TM
Schlom, J
Guyre, PM
Ernstoff, MS
Fanger, MW
Citation: Pk. Wallace et al., Exogenous antigen targeted to Fc gamma RI on myeloid cells is presented inassociation with MHC class I, J IMMUNOL M, 248(1-2), 2001, pp. 183-194
Authors:
Zhu, MZ
Terasawa, H
Gulley, J
Panicali, D
Arlen, P
Schlom, J
Tsang, KY
Citation: Mz. Zhu et al., Enhanced activation of human T cells via avipox vector-mediated hyperexpression of a triad of costimulatory molecules in human dendritic cells, CANCER RES, 61(9), 2001, pp. 3725-3734
Authors:
Tsang, KY
Zhu, MZ
Even, J
Gulley, J
Arlen, P
Schlom, J
Citation: Ky. Tsang et al., The infection of human dendritic cells with recombinant avipox vectors expressing a costimulatory molecule transgene (CD80) to enhance the activationof antigen-specific cytolytic T cells, CANCER RES, 61(20), 2001, pp. 7568-7576
Authors:
Schlom, J
Tsang, KY
Hodge, JW
Greiner, JW
Citation: J. Schlom et al., Carcinoembryonic antigen as a vaccine target, IMMUNOL MED, 30, 2001, pp. 73-100
Authors:
von Mehren, M
Arlen, P
Tsang, KY
Rogatko, A
Meropol, N
Cooper, HS
Davey, M
McLaughlin, S
Schlom, J
Weiner, LM
Citation: M. Von Mehren et al., Pilot study of a dual gene recombinant avipox vaccine containing both carcinoembryonic antigen (CEA) and B7.1 transgenes in patients with recurrent CEA-expressing adenocarcinomas, CLIN CANC R, 6(6), 2000, pp. 2219-2228
Authors:
Eder, JP
Kantoff, PW
Roper, K
Xu, GX
Bubley, GJ
Boyden, J
Gritz, L
Mazzara, G
Oh, WK
Arlen, P
Tsang, KY
Panicali, D
Schlom, J
Kufe, DW
Citation: Jp. Eder et al., A phase I trial of a recombinant vaccinia virus expressing prostate-specific antigen in advanced prostate cancer, CLIN CANC R, 6(5), 2000, pp. 1632-1638
Authors:
Zhu, MZ
Marshall, J
Cole, D
Schlom, J
Tsang, KY
Citation: Mz. Zhu et al., Specific cytolytic T-cell responses to human CEA from patients immunized with recombinant avipox-CEA vaccine, CLIN CANC R, 6(1), 2000, pp. 24-33
Authors:
Marshall, JL
Hoyer, RJ
Toomey, MA
Faraguna, K
Chang, P
Richmond, E
Pedicano, JE
Gehan, E
Peck, RA
Arlen, P
Tsang, KY
Schlom, J
Citation: Jl. Marshall et al., Phase I study in advanced cancer patients of a diversified prime-and-boostvaccination protocol using recombinant vaccinia virus and recombinant nonreplicating avipox virus to elicit anti-carcinoembryonic antigen immune responses, J CL ONCOL, 18(23), 2000, pp. 3964-3973
Authors:
Arlen, P
Tsang, KY
Marshall, JL
Chen, A
Steinberg, SM
Poole, D
Hand, PH
Schlom, J
Hamilton, JM
Citation: P. Arlen et al., The use of a rapid ELISPOT assay to analyze peptide-specific immune responses in carcinoma patients to peptide vs. recombinant poxvirus vaccines, CANCER IMMU, 49(10), 2000, pp. 517-529
Authors:
Deechongkit, S
Kennedy, RJ
Tsang, KY
Renold, P
Kemp, DS
Citation: S. Deechongkit et al., An amino acid that controls polypeptide helicity: beta-amino alanine, the first strongly stabilizing C-terminal helix stop signal, TETRAHEDR L, 41(49), 2000, pp. 9679-9683
Authors:
Wong, WY
Tsang, KY
Tam, KH
Lu, GL
Sun, CD
Citation: Wy. Wong et al., Synthesis, structures and luminescent properties of metal complexes containing 4-[2-(9-anthryl)vinyl] pyridine, J ORGMET CH, 601(2), 2000, pp. 237-245
Authors:
Salazar, E
Zaremba, S
Arlen, PM
Tsang, KY
Schlom, J
Citation: E. Salazar et al., Agonist peptide from a cytotoxic T-lymphocyte epitope of human carcinoembryonic antigen stimulates production of TC1-type cytokines and increases tyrosine phosphorylation more efficiently than cognate peptide, INT J CANC, 85(6), 2000, pp. 829-838
Authors:
Ngai, KL
Tsang, KY
Citation: Kl. Ngai et Ky. Tsang, Similarity of relaxation in supercooled liquids and interacting arrays of oscillators, PHYS REV E, 60(4), 1999, pp. 4511-4517
Authors:
Marshall, JL
Hawkins, MJ
Tsang, KY
Richmond, E
Pedicano, JE
Zhu, MZ
Schlom, J
Citation: Jl. Marshall et al., Phase I study in cancer patients of a replication-defective avipox recombinant vaccine that expresses human carcinoembryonic antigen, J CL ONCOL, 17(1), 1999, pp. 332-337
Authors:
Schlom, J
Tsang, KY
Kantor, JA
Abrams, SI
Zaremba, S
Greiner, J
Hodge, JW
Citation: J. Schlom et al., Strategies in the development of recombinant vaccines for colon cancer, SEMIN ONCOL, 26(6), 1999, pp. 672-682
Risultati:
1-20
|